Sharemaestro Newsreel

How Do AptarGroup’s (ATR) Dividend And Sustainability Honors Reframe Its Competitive Moat Narrative?

Azenta earnings on deck: Can life sciences firm return to profit?

Azenta Inc. is scheduled to report its fiscal third-quarter earnings, with analysts expecting a return to profitability at $0.10 per share on $149.29 million in revenue, a significant improvement from the previous quarter's loss. Investors will be closely watching for sustained profitability, North American …

Confluence Investment Management LLC Has $18.34 Million Stock Position in ResMed Inc. $RMD

Confluence Investment Management LLC reduced its stake in ResMed Inc. (NYSE:RMD) by 5.8% in Q2, now holding 94,086 shares valued at $18.34 million. Despite this reduction, institutional ownership remains significant at 54.98%, with other firms like AllianceBernstein increasing their positions. ResMed shares opened at …

Sanara MedTech (NASDAQ:SMTI) Stock Rating Lowered by Freedom Capital

Freedom Capital downgraded Sanara MedTech (NASDAQ:SMTI) from "strong buy" to "hold," aligning with several other recent rating cuts for the company. The current analyst consensus is "Reduce," with a $35.00 price target, and SMTI is trading near its 52-week high at $34.00. Institutional investors, …

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A

Bernstein Liebhard LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased shares between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made false and misleading statements about its business, leading …

DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?

DENTSPLY SIRONA (XRAY) is scheduled to release its second-quarter 2026 results, with analysts expecting revenues of $883.9 million and earnings of 36 cents per share. The company's "Return-to-Growth" action plan and ongoing investments are key factors, alongside challenges from dealer inventory adjustments, tariffs, and …

LeMaitre Q2 2026 Financial Results

LeMaitre Vascular, Inc. reported strong Q2 2026 financial results with sales up 10% to $70.4 million and EPS up 23% to $0.74, driven by a 34% increase in Artegraft sales and operational efficiencies. The company announced a quarterly dividend of $0.25/share and provided optimistic …

LeMaitre: Q2 Earnings Snapshot

LeMaitre Vascular Inc. (LMAT) reported a second-quarter profit of $17.1 million, or 74 cents per share, on revenue of $70.4 million. The medical device maker anticipates revenue for the current quarter to be between $66.3 million and $68.3 million, with full-year earnings projected at …

Align Tech (ALGN) Receives a Buy from Citi

Citi analyst Daniel Grosslight reiterated a Buy rating for Align Tech (ALGN) with a price target of $240.00. This follows a similar Buy rating from Barclays and comes despite a Sell rating from Bank of America Securities. Align Tech reported a quarterly revenue of …

Stevanato Group (NYSE:STVN) Releases Earnings Results, Beats Expectations By $0.01 EPS

Stevanato Group (NYSE:STVN) Updates FY 2026 Earnings Guidance

Merit Medical Systems (MMSI) Stock Looks Undervalued On Cash Flow But Overvalued On Earnings

STAAR Surgical Company Revenue Breakdown – NASDAQ:STAA

This article provides a breakdown of STAAR Surgical Company's (NASDAQ: STAA) revenue. Last year, the company generated $239.44 million USD, with its top-performing segment, Non-consignment, contributing $178.99 million USD. The "Other" segment accounted for $93.84 million USD last year.

JPMorgan Adjusts Price Target on Baxter International to $26 From $19, Maintains Neutral Rating

JPMorgan has raised its price target for Baxter International (BAX) to $26 from $19, while maintaining a Neutral rating on the stock. This adjustment comes after other analysts, including UBS, Wells Fargo, Jefferies & Co, Deutsche Bank, and Citigroup, also updated their price targets …

Senior Vice President of Regulatory Affairs Warren Nighan Sold A Bunch Of Shares In AngioDynamics

Warren Nighan, Senior Vice President of Regulatory Affairs at AngioDynamics, recently sold US$344k worth of stock, representing 27% of his holding. While insiders did buy some shares in the last year, the overall trend points to more selling than buying. This sale, the largest …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA

Faruqi & Faruqi, LLP is investigating potential claims against DENTSPLY SIRONA Inc. (NASDAQ: XRAY) on behalf of investors who suffered losses exceeding $75,000 between February 28, 2022, and November 6, 2024. The investigation stems from allegations that Dentsply made misleading statements and failed to …

Utah Medical sets 31-cent payment for shareholders on Oct. 5

Utah Medical Products (Nasdaq: UTMD) announced that its Board of Directors has approved a quarterly cash dividend of $0.31 per share of common stock. This dividend, representing a 1.6% increase over the previous year's dividend for the same quarter, is payable on October 5, …

Utah Medical Products raises quarterly dividend 1.6% By Investing.com

Utah Medical Products Inc. (NASDAQ:UTMD) has announced a quarterly cash dividend of $0.31 per share of common stock, representing a 1.6% increase from the previous year's dividend. The dividend will be payable on October 5, 2026, to shareholders of record as of September 17, …

Teleflex Closes $1.5B OEM Sale; Business Rebrands as Ingenyx

Teleflex has completed the divestiture of its OEM business to Montagu and Kohlberg for $1.5 billion in cash, with net proceeds estimated at $1.25 billion. The OEM business will now operate independently under the new brand Ingenyx, aiming to accelerate innovation and expand its …

Dentsply Sirona’s Endo Forum 2026 explores advances in endodontic care

Dentsply Sirona's Endo Forum 2026 brought together over 80 endodontic experts in Spain to discuss advancements, emerging trends, and future innovations in endodontic care. The event facilitated dialogue between clinicians and Dentsply Sirona's product development teams, leading to discussions on digital workflows, new products …

EMBC UPCOMING DEADLINE : The Gross Law Firm Alerts Embecta Corp. Stockholders of Securities Class Action - Contact the Firm

The Gross Law Firm has issued a notice to shareholders of Embecta Corp. (NASDAQ: EMBC) regarding a securities class action lawsuit. The lawsuit alleges that Embecta made misleading statements about its financial performance, particularly concerning its pen needle business, leading to a significant stock …

Stevanato Group Q2 2026 Earnings Call: Complete Transcript

Stevanato Group reported an 8% year-over-year revenue growth in Q2 2026, reaching $302 million, driven by strong demand for injectable biologics and GLP-1 therapies. The company divested its California subsidiary, Balda C. Brewer, to focus on higher-value integrated drug delivery systems, a move expected …

Teleflex Medical OEM Launches as INGENYX to Empower Tomorrow’s MedTech Innovators

INGENYX, formerly Teleflex Medical OEM, has launched as an independent company after its acquisition by Montagu and Kohlberg. The company aims to accelerate innovation in the MedTech industry by expanding engineering capabilities and strengthening customer collaboration, building on over 40 years of experience in …

Stevanato Group (STVN) Q2 Earnings Top Estimates

Stevanato Group (STVN) reported Q2 earnings of $0.16 per share, surpassing the Zacks Consensus Estimate of $0.15, and revenues of $351.09 million, which slightly missed the consensus. The company has consistently beaten EPS estimates over the past four quarters and currently holds a Zacks …

Baxter International launches $500M cash tender offers for select long-dated notes

Baxter International has commenced cash tender offers to repurchase up to $500 million of select senior notes, providing an early tender premium of $30 per $1,000. The offer prioritizes notes from 2051, 2046, 2043, and 2032, with an early settlement option for tenders by …

EMBC Stock Drop: Embecta Insulin Pen Issues Lead to 57% Stock Drop and Securities Fraud Class Action for Investors

|

Stevanato Group SpA earnings beat by €0.01, revenue topped estimates

Stevanato Group SpA (NYSE: STVN) reported strong second-quarter results, with EPS of €0.14 surpassing analyst estimates by €0.01 and revenue reaching €302M, exceeding the consensus estimate of €298.64M. The company's stock has seen a 14.20% increase in the last three months, despite a 10.83% …

Marc Prieur plans Aptargroup (ATR) sale of 3,500 common shares

Marc Prieur, a shareholder of Aptargroup, Inc. (ATR), has filed an intention to sell up to 3,500 common shares held through UBS Switzerland AG. This proposed sale, valued at approximately $476,000, is linked to equity awards granted as RSUs and PSUs on March 14, …

ALGN Q2 Deep Dive: Clear Aligner Volumes Grow, Guidance Flags Scanner Mix Shift

Align Technology (NASDAQ:ALGN) reported Q2 CY2026 revenue that met Wall Street expectations, with a 4.3% year-on-year increase to $1.06 billion, and adjusted EPS beating estimates. However, the company's Q3 revenue guidance of $1.01 billion fell below analyst estimates, largely due to an anticipated continued …

Repligen Corporation (BLFS) sets cash and stock terms for BioLife Solutions buyout

Repligen Corporation has entered into an Agreement and Plan of Merger to acquire BioLife Solutions for $11.25 in cash plus 0.1442 shares of Repligen common stock per BioLife share. The transaction is a strategic move in the cell therapy market, pending regulatory and BioLife …

Earnings To Watch: Nyxoah SA (XBRU:NYXH) Q2 2026 -- GF Value Sees 5209% Upside

Nyxoah SA (XBRU:NYXH) is scheduled to release its Q2 2026 earnings on August 5, 2026, with revenue expected at $7.60 million and earnings at $-0.39 per share. Analyst estimates for both revenue and earnings for 2026 and 2027 have shown improvement over the last …

LeMaitre Vascular, Inc. $LMAT Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC reduced its stake in LeMaitre Vascular, Inc. (LMAT) by 34.9% in the first quarter, selling 27,990 shares and retaining 52,252 shares valued at approximately $5.7 million. The medical instruments supplier reported strong Q1 earnings, beating estimates with $0.68 EPS …

H.C. Wainwright raises Bausch & Lomb stock price target to $21

H.C. Wainwright has increased its price target for Bausch & Lomb Corp. (NYSE:BLCO) to $21 from $20, maintaining a Buy rating after the company reported strong second-quarter 2026 financial results. Bausch & Lomb exceeded revenue projections with $1,394 million and saw growth across all …

L1 Capital reduces holdings in Anteris Technologies Global Corp. (AVR)

L1 Capital Pty Ltd, acting as a ten percent owner of Anteris Technologies Global Corp. (AVR), reported the indirect sale of 524,404 common shares through funds it manages on July 31 and August 3, 2026, with prices ranging from $8.09 to $8.15 per share. …

Anteris Technologies Global granted Federal Court orders to rectify late cleansing notice

Anteris Technologies Global has secured Federal Court orders to address a late cleansing notice and protect affected CHESS Depositary Interests (CDIs). The Federal Court of Australia extended the s 708A(6)(a) period to July 31, 2026, for 44,068 impacted CDIs issued on July 10, 2026, …

Confluence Investment Management LLC Takes $20.15 Million Position in AptarGroup, Inc. $ATR

Confluence Investment Management LLC has acquired a new stake worth $20.15 million in AptarGroup, Inc. (NYSE:ATR) during the second quarter, representing 0.25% of the company. Institutional investors now collectively own 88.52% of AptarGroup, which recently exceeded Q2 earnings expectations with adjusted EPS of $1.42 …